Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
SAN JOSE, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that the United States District Court for the Northern District of California has approved the following announcement of a...
-
NEW YORK, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against FXCM Inc. (“FXCM” or the “Company”) (NASDAQ:FXCM) and certain of its...
-
NEW YORK, Feb. 08, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Stemline Therapeutics, Inc. (“Stemline” or the “Company”) (NASDAQ:STML) and...
-
NEW YORK, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Kitov Pharmaceuticals Holdings Ltd. (“Kitov” or the “Company”) (Nasdaq:KTOV)...
-
NEW YORK, Feb. 06, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Aratana Therapeutics, Inc. (“Aratana” or the “Company”) (NASDAQ:PETX) and...
-
NEW YORK, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Agile Therapeutics, Inc. (“Agile” or the “Company”) (NASDAQ:AGRX) and certain...
-
NEW YORK, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against DaVita Inc. (“DaVita” or the “Company”) (NYSE:DVA) and certain of its...
-
NEW YORK, Feb. 03, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Psychemedics Corporation (“Psychemedics” or the “Company”) (NASDAQ:PMD) and...
-
NEW YORK, Feb. 01, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Roadrunner Transportation Systems Inc. (“Roadrunner” or the “Company”)...
-
NEW YORK, Jan. 31, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Regulus Therapeutics Inc. (“Regulus” or the “Company”) (NASDAQ:RGLS) and...